
Torvastat 35mg Tablet MR
Marketer
Biochem Pharmaceutical Industries
Salt Composition
Trimetazidine (35mg)
Overview Torvastat 35mg Tablet MR
Cardiostat 35mg Extended-Release Tablets are prescribed for angina pectoris, a type of chest pain linked to the heart. This medication serves as a preventative measure against future angina episodes; however, it's ineffective during an ongoing attack. It can be administered independently or alongside other cardiac medications, as determined by your physician. Consistent daily use, as directed, is crucial. Take Cardiostat 35mg with or without food, maintaining a regular schedule. Your doctor may adjust the dosage frequency based on treatment effectiveness. Continuous use, even during symptom-free periods, maximizes its protective benefits. Discontinuing treatment may lead to angina recurrence. Complementing medication with a heart-healthy lifestyle – including smoking cessation, moderate alcohol consumption, balanced nutrition, regular physical activity, and stress management – is strongly recommended. Potential side effects include, but aren't limited to, vertigo, headache, stomach upset, diarrhea, dyspepsia, nausea, emesis, skin rashes, pruritus, urticaria, and fatigue. Consult your doctor if these side effects persist or are bothersome. Prior to starting Cardiostat 35mg, inform your physician of any pre-existing liver or kidney conditions, pregnancy, breastfeeding, or other concurrent medications.
Uses of Torvastat 35mg Tablet MR
Managing Chest Pain Associated with Coronary Artery Disease
Major Benefits of Torvastat 35mg Tablet MR:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Torvastat 35mg Modified-Release tablet should be administered with a meal.
Common Side effects of Torvastat 35mg Tablet MR:
- Dizziness
- Headache
- Nausea
- Vomiting
- Weakness
- Rash
- Abdominal pain
- Indigestion
- Itching
- Diarrhea
- Hives
How to use Torvastat 35mg Tablet MR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 35mg Torvastat MR tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
How Torvastat 35mg Tablet MR works:
Torvastat 35mg Modified-Release tablets offer angina relief by altering cardiac metabolism. This medication reduces the heart's oxygen demand through a metabolic shift from fatty acids to glucose, thus enhancing cardiac efficiency.
SAFETY ADVICE
AlcoholUNSAFE
Taking Torvastatin 35mg Modified-Release tablets with alcohol can lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Data on Torvastat 35mg MR Tablet use in pregnancy are lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Torvastat 35mg Modified-Release tablets with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Torvastatin 35mg Modified-Release tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if such effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Torvastat 35mg Modified-Release tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. Torvastat 35mg Modified-Release tablets are contraindicated in individuals with severe kidney disease.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Torvastat 35mg Modified-Release tablets in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Torvastat 35mg Tablet MR :
Should you forget to take your 35mg modified-release Torvastat tablet, ingest it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Never take a double dose.
Facts to Know About Torvastat 35mg Tablet MR
| Label | Value |
|---|---|
| Type of Compound | Benzylamines |
| Potential for Dependence | None. |
| Medication Classification | HEART |
| Mechanism of Action | Lipid regulator and sodium channel antagonist |
